Extended Release Metformin Hydrochloride clinical trials

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

This study investigates if metformin, a common diabetes drug, can prevent oral cancer in people with white or red patches in their mouth (leukoplakia or erythroplakia). Participants will take either metformin or a dummy pill for 24 weeks.